Additional file 1: Table S1. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

Publication date

September 2015

DOI

10.6084/m9.figshare.c.3640676_d3.v1

Abstract

Details of primary antibodies used in the study. Details of primary antibodies used in the study including antibody clone, manufacturer and dilution used for each antibody

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 1: Table S1. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

Open link

Publication date

September 2015

DOI

10.6084/m9.figshare.c.3640676_d3.v1

Abstract

Details of primary antibodies used in the study. Details of primary antibodies used in the study including antibody clone, manufacturer and dilution used for each antibody

Extracted data

Minako Sakurai (4126699)
Yasuhiro Miki (368958)
Kiyoshi Takagi (4126696)
Takashi Suzuki (8491)
Takanori Ishida (822205)
Noriaki Ohuchi (360735)
Hironobu Sasano (368960)

June 2017

Supplementary information with materials and methods for supplementary figures, legends of Figures S...

Additional file 1: of Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma

Karsten Kleo (3750175)
Lora Dimitrova (3750178)
Elisabeth Oker (197155)
Nancy Tomaszewski (6561332)
Erika Berg (84732)
Franziska Taruttis (1555381)
Julia Engelmann (3440546)
Philipp Schwarzfischer (3750184)
Jรถrg Reinders (6561335)
Rainer Spang (21155)
Wolfram Gronwald (65407)
Peter Oefner (3470186)
Michael Hummel (197180)

April 2019

Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...

Additional file 3: Figure S2. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

September 2015

ALK expression in triple-negative breast cancer cell line versus normal cell line. (A) Total protein...

Additional file 3: of Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer

Maria Grinde (6701054)
Bylgja Hilmarsdottir (207231)
Hanna Tunset (6701063)
Ida Henriksen (6701066)
Jana Kim (6701069)
Mads Haugen (6701072)
Morten Rye (725101)
Gunhild MĂŚlandsmo (5515103)
Siver Moestue (6701075)

May 2019

Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...

Additional file 4: Figure S3. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

September 2015

Kaplan-Meier survival analysis for overall survival of ALK expression in breast cancer. Breast cance...

Additional file 2: Table S1. of The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Andrea Aloia (3562976)
Evgeniya Petrova (3563009)
Stefan Tomiuk (831767)
Ute Bissels (747002)
Olivier DĂŠas (3563027)
Massimo Saini (3563000)
Franziska Zickgraf (3562979)
Steve Wagner (695522)
Saskia Spaich (3563015)
Marc SĂźtterlin (3563030)
Andreas Schneeweiss (146474)
Manuel Reitberger (3562991)
Silvia RĂźberg (3563024)
Bernhard Gerstmayer (3563003)
David Agorku (3563018)
Sebastian KnĂśbel (3563021)
Annalisa Terranegra (3486953)
Monica Falleni (3562994)
Laura Soldati (484680)
Martin Sprick (3562985)
Andreas Trumpp (259351)
Jean-Gabriel Judde (3562988)
Andreas Bosio (599151)
Stefano Cairo (3563012)
Olaf Hardt (3563006)

November 2015

Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb

Additional file 1: Table S1. of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion

Hanan Elsarraj (3557555)
Yan Hong (80440)
Kelli Valdez (3557546)
Whitney Michaels (3557525)
Marcus Hook (3557552)
William Smith (517181)
Jeremy Chien (185202)
Jason Herschkowitz (3557564)
Melissa Troester (3403661)
Moriah Beck (3557549)
Marc Inciardi (3557537)
Jason Gatewood (3557528)
Lisa May (3557561)
Therese Cusick (3557531)
Marilee McGinness (3557543)
Lawrence Ricci (3557534)
Fang Fan (334244)
Ossama Tawfik (276135)
Jeffrey Marks (711578)
Jennifer Knapp (3432767)
Hung-Wen Yeh (3557558)
Patricia Thomas (3489989)
D. Carrasco (3557540)
Timothy Fields (3557567)
Andrew Godwin (811543)
Fariba Behbod (3505388)

September 2015

List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...

Additional file 1: of Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR

Ryohei Yoshida (5990975)
Takaaki Sasaki (1277619)
Yasuhiro Umekage (5990978)
Sachie Tanno (5990981)
Yusuke Ono (149099)
Munehiko Ogata (5990984)
Shinichi Chiba (5990987)
Yusuke Mizukami (254859)
Yoshinobu Ohsaki (5990990)

November 2018

Table S1. Reaction mixtures. (A) Screening assay. (B) Mutant specific assay. Table S2. Thermal cycli...

Additional file 1: of Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage

Zhangjian Zhou (2575213)
Heng Lu (789992)
Shoumin Zhu (415788)
Ahmed Gomaa (4115773)
Zheng Chen (49483)
Jin Yan (193119)
Kay Washington (6192839)
Wael El-Rifai (303374)
Chengxue Dang (447920)
Dunfa Peng (6192842)

January 2019

Table S1. IGFBP2 siRNAs target sequences. Table S2. Information of antibodies used in this study. (P...

Additional file 1: of Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer

Ching-Chieh Weng (6716045)
Mei-Jen Hsieh (6716048)
Chia-Chen Wu (392526)
Yu-Chun Lin (36446)
Yan-Shen Shan (424776)
Wen-Chun Hung (303185)
Li-Tzong Chen (388257)
Kuang-Hung Cheng (771984)

May 2019

Table S1. List of the primary antibodies used in this study, and information on working dilutions of...

Additional file 1: of Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression

Jin-Yong He (6100892)
Xiao-Hui Wei (6100895)
Si-Jing Li (6100898)
Yang Liu (4829)
Hao-Lin Hu (6100901)
Zheng-Zheng Li (1637104)
Xin-Hong Kuang (6100904)
Lai Wang (23747)
Xin Shi (139139)
Sheng-Tao Yuan (6100907)
Li Sun (4624)

December 2018

Table S1. Sequences of the primers used to detect gene expression by qRT-PCR. Table S2. Characteriza...

Additional file 1: of Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Nadine Norton (488827)
Nicholas Fox (5392982)
Christie-Ann McCarl (5392979)
Kathleen Tenner (5392988)
Karla Ballman (404207)
Courtney Erskine (5392991)
Brian Necela (3664780)
Donald Northfelt (4609261)
Winston Tan (5392994)
Carmen Calfa (5392985)
Mark Pegram (3568463)
Gerardo Colon-Otero (3472709)
Edith Perez (3439139)
Raphael Clynes (326829)
Keith Knutson (376781)

June 2018

Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...

Additional file 1: Table S1. of A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

Kerry Reynolds (4431211)
Philippe Bedard (362729)
Se-Hoon Lee (73313)
Chia-Chi Lin (1849147)
Josep Tabernero (237681)
Maria Alsina (4431229)
Ezra Cohen (4431199)
JosĂŠ Baselga (4431244)
George Blumenschein (4431226)
Donna Graham (4431205)
Ignacio Garrido-Laguna (160665)
Dejan Juric (4431196)
Sunil Sharma (435513)
Ravi Salgia (253953)
Abdelkader Seroutou (4431223)
Xianbin Tian (2004925)
Rose Fernandez (4431220)
Alex Morozov (4431202)
Qing Sheng (50321)
Thiruvamoor Ramkumar (4431217)
Angela Zubel (4431214)
Yung-Jue Bang (73319)

September 2017

Summary of criteria for dose-limiting toxicities (CTCAE version 4.03 grading). Footnote: ALT alanine...

Additional file 1: of Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment

Minako Sakurai (4126699)
Yasuhiro Miki (368958)
Kiyoshi Takagi (4126696)
Takashi Suzuki (8491)
Takanori Ishida (822205)
Noriaki Ohuchi (360735)
Hironobu Sasano (368960)

June 2017

Supplementary information with materials and methods for supplementary figures, legends of Figures S...

Additional file 1: of Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma

Karsten Kleo (3750175)
Lora Dimitrova (3750178)
Elisabeth Oker (197155)
Nancy Tomaszewski (6561332)
Erika Berg (84732)
Franziska Taruttis (1555381)
Julia Engelmann (3440546)
Philipp Schwarzfischer (3750184)
Jรถrg Reinders (6561335)
Rainer Spang (21155)
Wolfram Gronwald (65407)
Peter Oefner (3470186)
Michael Hummel (197180)

April 2019

Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...

Additional file 3: Figure S2. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

September 2015

ALK expression in triple-negative breast cancer cell line versus normal cell line. (A) Total protein...

Additional file 3: of Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer

Maria Grinde (6701054)
Bylgja Hilmarsdottir (207231)
Hanna Tunset (6701063)
Ida Henriksen (6701066)
Jana Kim (6701069)
Mads Haugen (6701072)
Morten Rye (725101)
Gunhild MĂŚlandsmo (5515103)
Siver Moestue (6701075)

May 2019

Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...

Additional file 4: Figure S3. of ALK alteration is a frequent event in aggressive breast cancers

Abdul Siraj (3567338)
Shaham Beg (3567347)
Zeenath Jehan (3567341)
Sarita Prabhakaran (3567353)
Maqbool Ahmed (154386)
Azhar R.Hussain (3567344)
Fouad Al-Dayel (396120)
Asma Tulbah (79417)
Dahish Ajarim (197836)
Khawla Al-Kuraya (3567350)

September 2015

Kaplan-Meier survival analysis for overall survival of ALK expression in breast cancer. Breast cance...

Additional file 2: Table S1. of The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Andrea Aloia (3562976)
Evgeniya Petrova (3563009)
Stefan Tomiuk (831767)
Ute Bissels (747002)
Olivier DĂŠas (3563027)
Massimo Saini (3563000)
Franziska Zickgraf (3562979)
Steve Wagner (695522)
Saskia Spaich (3563015)
Marc SĂźtterlin (3563030)
Andreas Schneeweiss (146474)
Manuel Reitberger (3562991)
Silvia RĂźberg (3563024)
Bernhard Gerstmayer (3563003)
David Agorku (3563018)
Sebastian KnĂśbel (3563021)
Annalisa Terranegra (3486953)
Monica Falleni (3562994)
Laura Soldati (484680)
Martin Sprick (3562985)
Andreas Trumpp (259351)
Jean-Gabriel Judde (3562988)
Andreas Bosio (599151)
Stefano Cairo (3563012)
Olaf Hardt (3563006)

November 2015

Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb

Additional file 1: Table S1. of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion

Hanan Elsarraj (3557555)
Yan Hong (80440)
Kelli Valdez (3557546)
Whitney Michaels (3557525)
Marcus Hook (3557552)
William Smith (517181)
Jeremy Chien (185202)
Jason Herschkowitz (3557564)
Melissa Troester (3403661)
Moriah Beck (3557549)
Marc Inciardi (3557537)
Jason Gatewood (3557528)
Lisa May (3557561)
Therese Cusick (3557531)
Marilee McGinness (3557543)
Lawrence Ricci (3557534)
Fang Fan (334244)
Ossama Tawfik (276135)
Jeffrey Marks (711578)
Jennifer Knapp (3432767)
Hung-Wen Yeh (3557558)
Patricia Thomas (3489989)
D. Carrasco (3557540)
Timothy Fields (3557567)
Andrew Godwin (811543)
Fariba Behbod (3505388)

September 2015

List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...

Additional file 1: of Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR

Ryohei Yoshida (5990975)
Takaaki Sasaki (1277619)
Yasuhiro Umekage (5990978)
Sachie Tanno (5990981)
Yusuke Ono (149099)
Munehiko Ogata (5990984)
Shinichi Chiba (5990987)
Yusuke Mizukami (254859)
Yoshinobu Ohsaki (5990990)

November 2018

Table S1. Reaction mixtures. (A) Screening assay. (B) Mutant specific assay. Table S2. Thermal cycli...

Additional file 1: of Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage

Zhangjian Zhou (2575213)
Heng Lu (789992)
Shoumin Zhu (415788)
Ahmed Gomaa (4115773)
Zheng Chen (49483)
Jin Yan (193119)
Kay Washington (6192839)
Wael El-Rifai (303374)
Chengxue Dang (447920)
Dunfa Peng (6192842)

January 2019

Table S1. IGFBP2 siRNAs target sequences. Table S2. Information of antibodies used in this study. (P...

Additional file 1: of Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer

Ching-Chieh Weng (6716045)
Mei-Jen Hsieh (6716048)
Chia-Chen Wu (392526)
Yu-Chun Lin (36446)
Yan-Shen Shan (424776)
Wen-Chun Hung (303185)
Li-Tzong Chen (388257)
Kuang-Hung Cheng (771984)

May 2019

Table S1. List of the primary antibodies used in this study, and information on working dilutions of...

Additional file 1: of Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression

Jin-Yong He (6100892)
Xiao-Hui Wei (6100895)
Si-Jing Li (6100898)
Yang Liu (4829)
Hao-Lin Hu (6100901)
Zheng-Zheng Li (1637104)
Xin-Hong Kuang (6100904)
Lai Wang (23747)
Xin Shi (139139)
Sheng-Tao Yuan (6100907)
Li Sun (4624)

December 2018

Table S1. Sequences of the primers used to detect gene expression by qRT-PCR. Table S2. Characteriza...

Additional file 1: of Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Nadine Norton (488827)
Nicholas Fox (5392982)
Christie-Ann McCarl (5392979)
Kathleen Tenner (5392988)
Karla Ballman (404207)
Courtney Erskine (5392991)
Brian Necela (3664780)
Donald Northfelt (4609261)
Winston Tan (5392994)
Carmen Calfa (5392985)
Mark Pegram (3568463)
Gerardo Colon-Otero (3472709)
Edith Perez (3439139)
Raphael Clynes (326829)
Keith Knutson (376781)

June 2018

Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...

Kerry Reynolds (4431211)
Philippe Bedard (362729)
Se-Hoon Lee (73313)
Chia-Chi Lin (1849147)
Josep Tabernero (237681)
Maria Alsina (4431229)
Ezra Cohen (4431199)
JosĂŠ Baselga (4431244)
George Blumenschein (4431226)
Donna Graham (4431205)
Ignacio Garrido-Laguna (160665)
Dejan Juric (4431196)
Sunil Sharma (435513)
Ravi Salgia (253953)
Abdelkader Seroutou (4431223)
Xianbin Tian (2004925)
Rose Fernandez (4431220)
Alex Morozov (4431202)
Qing Sheng (50321)
Thiruvamoor Ramkumar (4431217)
Angela Zubel (4431214)
Yung-Jue Bang (73319)

September 2017

Summary of criteria for dose-limiting toxicities (CTCAE version 4.03 grading). Footnote: ALT alanine...

Additional file 1: of Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment

Minako Sakurai (4126699)
Yasuhiro Miki (368958)
Kiyoshi Takagi (4126696)
Takashi Suzuki (8491)
Takanori Ishida (822205)
Noriaki Ohuchi (360735)
Hironobu Sasano (368960)

June 2017

Supplementary information with materials and methods for supplementary figures, legends of Figures S...

Additional file 1: of Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma

Karsten Kleo (3750175)
Lora Dimitrova (3750178)
Elisabeth Oker (197155)
Nancy Tomaszewski (6561332)
Erika Berg (84732)
Franziska Taruttis (1555381)
Julia Engelmann (3440546)
Philipp Schwarzfischer (3750184)
Jรถrg Reinders (6561335)
Rainer Spang (21155)
Wolfram Gronwald (65407)
Peter Oefner (3470186)
Michael Hummel (197180)

April 2019

Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...

Additional file 1: Table S1. of ALK alteration is a frequent event in aggressive breast cancers

Abstract

Extracted data

Additional file 1: Table S1. of ALK alteration is a frequent event in aggressive breast cancers

Abstract

Extracted data

Related items

Related items